Relation between microRNA‐21, transforming growth factor β and response to treatment among chronic hepatitis C patients

Persistence of hepatitis C virus (HCV) infection and response to antiviral therapy has been shown to be associated with inappropriate levels of cytokines and microRNAs (miRNAs). miRNA levels have been reported to fluctuate during treatment. Thus they could be useful predictors for responses to treatment among HCV infected patients, thereby reducing ineffective treatments.

• Publication year

  2019

• Venue

  Journal of Medical Virology

• Publication date

  2019-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jmv.25559PMID 31368531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C Virus.

  2019cited by this paper
• Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy.

  2018cited by this paper
• miRNAs regulate immune response and signaling during hepatitis C virus infection

  2018cited by this paper
• Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver biopsy for detection of hepatic fibrosis in Egyptian patients with chronic hepatitis C

  2017cited by this paper
• Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis

  2017cited by this paper
• The effect of the hepatitis C virus (HCV) NS3 protein on the expression of miR-150, miR-199a, miR-335, miR-194 and miR-27a.

  2017cited by this paper
• MicroRNAs in hepatic pathophysiology

  2017cited by this paper
• The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment

  2016influential reference
• The Role of Circulating MicroRNAs as Markers of Disease Progression in Hepatitis C Virus Infected Egyptian Patients

  2016cited by this paper
• Hepatitis C Virus

  2016cited by this paper
• The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study

  2016cited by this paper
• Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis

  2015cited by this paper
• Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety

  2015cited by this paper
• MicroRNAs as Predictor Markers for Response to Interferon Treatment of Chronic Hepatitis C Genotype-4 in Egyptian Patients

  2015influential reference
• Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.

  2015cited by this paper
• Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

  2015cited by this paper
• Expression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis C.

  2015cited by this paper
• Differences in serum microRNA profiles in hepatitis B and C virus infection.

  2015cited by this paper
• Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

  2015cited by this paper
• MicroRNAs: Role in hepatitis C virus pathogenesis

  2015cited by this paper
• Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease

  2014cited by this paper
• Global Distribution and Prevalence of Hepatitis C Virus Genotypes

  2014cited by this paper
• Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma

  2014cited by this paper
• Prognostic significance of transforming growth factor-beta-1 in chronic hepatitis C virus infection

  2012cited by this paper
• An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region

  2012cited by this paper
• Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma

  2011cited by this paper
• Smad3-mediated upregulation of miR-21 promotes renal fibrosis.

  2011cited by this paper
• Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans

  2010influential reference
• Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.

  2000cited by this paper

• Differential effects of microRNAs miR‐21, miR‐99 and miR‐145 on lung regeneration and inflammation during recovery from influenza pneumonia

  2023cites this paper
• Genetic polymorphisms of Endoplasmic reticulum amino peptidase 1 (ERAP1) and Interferon lambda 4 (IFN-λ4) in Egyptian patients with type 1 diabetes mellitus.

  2023cites this paper
• Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR‐192 and miR‐21

  2023cites this paper
• 614-15El Nazar.indd

  2021cites this paper
• microRNA-21: a key modulator in oncogenic viral infections

  2021cites this paper
• The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs

  2020cites this paper
• Serum MicroRNAs as predictors for fibrosis progression and response to direct‐acting antivirals treatment in hepatitis C virus genotype‐4 Egyptian patients

  2020cites this paper
• Relation between HLA-DP/DQ Polymorphisms, Serum IP-10 and Response to Direct Acting Antiviral Therapy among HCV Infected Patients.

  2020cites this paper